JAK inhibitor in CALR-mutant myelofibrosis

N Engl J Med. 2014 Mar 20;370(12):1168-9. doi: 10.1056/NEJMc1400499.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Calreticulin / genetics*
  • Humans
  • Mutation*
  • Myelodysplastic Syndromes / genetics*
  • Primary Myelofibrosis / genetics*
  • Thrombocythemia, Essential / genetics*

Substances

  • Calreticulin